Aryl Hydrocarbon Receptor (AHR) Peptid
AHR
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Aryl Hydrocarbon Receptor (AHR) Produkte
- Aryl Hydrocarbon Receptor (AHR)
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-AHR antibody (Catalog #: ARP32243_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Aryl Hydrocarbon Receptor (AHR)
- Hintergrund
-
AHR is a ligand-activated transcription factor involved in the regulation of biological responses to planar aromatic hydrocarbons. This receptor has been shown to regulate xenobiotic-metabolizing enzymes such as cytochrome P450. Its ligands included a variety of aromatic hydrocarbons.
Alias Symbols: bHLHe76
Protein Interaction Partner: ARNT,NCOA1,NCOA2,TAF4,TAF6,TBP,AHR,AIP,AR,ARNT,ARNTL,CCNT1,CUL4B,DAP3,EP300,ESR1,GTF2F2,HSP90AA1,NCOA1,NCOA2,NCOR2,NEDD8,NR2F1,NRIP1,PTGES3,RB1,RELA,SMARCA4,TAF4,TAF7,TBP,XPO1,AIP,ARNT,ARNTL,CCNT1,DAP3,ESR1,GTF2F1,GTF2F2,HSP90AA1,NCOA2,NEDD8,NR2F1,NRIP1,RB1,RELA,SMARCA4,SP1,SRC,STUB1,TBP
Protein Size: 848 - Molekulargewicht
- 96 kDa
- Gen-ID
- 196
- NCBI Accession
- NM_001621, NP_001612
- UniProt
- P35869
-
Sie sind hier:
